UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials

British journal of dermatology (1951), 2023-02, Vol.188 (3), p.330-340

2023

Volltextzugriff (PDF)

Becoming a global citizen: Belief vs. action

Advancements in agricultural development, 2023-01, Vol.4 (1), p.32-47

2023

Volltextzugriff (PDF)

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

Dermatology and therapy, 2022-01, Vol.12 (1), p.203-221

2022

Volltextzugriff (PDF)

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

Dermatology and therapy, 2022-03, Vol.12 (3), p.787-800

2022

Volltextzugriff (PDF)

Racial/ethnic and socioeconomic disparities in COVID-19 infections among working-age women with precancerous cervical lesion in Louisiana: analysis of more than two years of COVID-19 data

Frontiers in Epidemiology (Online), 2023-05, Vol.3, p.1108452-1108452

2023

Volltextzugriff (PDF)

Challenges to addressing trafficking into forced labor in Chile: a legal culture perspective

Crime, law, and social change, 2023-05, Vol.79 (4), p.395-416

2023

Volltextzugriff (PDF)

Accountability in International Governance and the 2030 Development Agenda

Global policy, 2016-09, Vol.7 (3), p.305-314

2016

Volltextzugriff (PDF)

27722 Biologic initiation rates in psoriasis after first-line systemic use of apremilast vs methotrexate

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB160-AB160

2021

Volltextzugriff (PDF)

26603 Real-world health outcomes in US adult patients with mild-to-moderate plaque psoriasis taking topical therapy: Results from a chart review

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB21-AB21

2021

Volltextzugriff (PDF)

Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.486-495

2023

Volltextzugriff (PDF)

33817 Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis who switched from secukinumab: Results from the open-label extension period of the BE RADIANT phase 3b trial

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB145-AB145

2022

Volltextzugriff (PDF)

34320 Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB146-AB146

2022

Volltextzugriff (PDF)

34310 Bimekizumab early responses in patients with plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB145-AB145

2022

Volltextzugriff (PDF)

Realizing the Asymmetric Index of a Graph

Journal of Combinatorial Mathematics and Combinatorial Computing, 2024-06, Vol.121 (1), p.17-29

2024

Volltextzugriff (PDF)

26698 Characteristics and disease burden in patients with mild to moderate vs severe plaque psoriasis in real-world settings: Results from the Corrona Psoriasis Registry

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB113-AB113

2021

Volltextzugriff (PDF)

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis

Dermatology and therapy, 2022-08, Vol.12 (8), p.1777-1792

2022

Volltextzugriff (PDF)

REIMAGINING PUBLIC EDUCATION EQUITY AFTER COVID-19: WILL PUBLIC VOICES FROM NEW YORK'S EPICENTER BE HEARD OVER THE SIREN SONG OF BILLIONAIRES?

The Fordham urban law journal, 2021-02, Vol.48 (2), p.313

Gomez-Velez, Natalie

2021

Volltextzugriff (PDF)

Análisis psicométrico de la Escala Unidimensional de Burnout Estudiantil en el contexto educativo universitario salvadoreño

Entorno (San Salvador), 2024-06, Vol.1 (76), p.138-147

2024

Volltextzugriff (PDF)

Wirksamkeit und Sicherheit von Fumarsäureestern in Kombination mit Phototherapie bei Patienten mit moderater bis schwerer Plaque-Psoriasis (FAST)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-02, Vol.15 (2), p.180-188

2017

Volltextzugriff (PDF)

Bimekizumab safety in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in phase 2 and 3 clinical trials

Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s66

2022

Volltextzugriff (PDF)

Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension

Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s68

2022

Volltextzugriff (PDF)

Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials

Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s67

2022

Volltextzugriff (PDF)

Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-02, Vol.15 (2), p.180-186

2017

Volltextzugriff (PDF)

Wirksamkeit und Sicherheit von Fumarsäureestern in Kombination mit Phototherapie bei Patienten mit moderater bis schwerer Plaque‐Psoriasis (FAST)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-02, Vol.15 (2), p.180-188

2017

Volltextzugriff (PDF)

Social protection systems, redistribution and growth in Latin America

CEPAL review, 2017-08 (122), p.7

2017

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(287)
Mit Volltextzugriff
(281)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(155)
Humans
(104)
Female
(58)
Male
(57)
Animals
(33)
Adult
(30)
Aged
(23)
Middle Aged
(23)
Child
(21)
Physical Sciences
(19)
Adolescent
(18)
Biochemistry & Molecular Biology
(17)
General & Internal Medicine
(17)
Mice
(17)
Medicine, General & Internal
(15)
Young Adult
(15)
Child, Preschool
(14)
Multidisciplinary Sciences
(14)
Science & Technology - Other Topics
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials

Becoming a global citizen: Belief vs. action

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

Racial/ethnic and socioeconomic disparities in COVID-19 infections among working-age women with precancerous cervical lesion in Louisiana: analysis of more than two years of COVID-19 data

Challenges to addressing trafficking into forced labor in Chile: a legal culture perspective

Accountability in International Governance and the 2030 Development Agenda

27722 Biologic initiation rates in psoriasis after first-line systemic use of apremilast vs methotrexate

26603 Real-world health outcomes in US adult patients with mild-to-moderate plaque psoriasis taking topical therapy: Results from a chart review

Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial

33817 Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis who switched from secukinumab: Results from the open-label extension period of the BE RADIANT phase 3b trial

34320 Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis

34310 Bimekizumab early responses in patients with plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial

Realizing the Asymmetric Index of a Graph

26698 Characteristics and disease burden in patients with mild to moderate vs severe plaque psoriasis in real-world settings: Results from the Corrona Psoriasis Registry

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis

REIMAGINING PUBLIC EDUCATION EQUITY AFTER COVID-19: WILL PUBLIC VOICES FROM NEW YORK'S EPICENTER BE HEARD OVER THE SIREN SONG OF BILLIONAIRES?

Análisis psicométrico de la Escala Unidimensional de Burnout Estudiantil en el contexto educativo universitario salvadoreño

Wirksamkeit und Sicherheit von Fumarsäureestern in Kombination mit Phototherapie bei Patienten mit moderater bis schwerer Plaque-Psoriasis (FAST)

Bimekizumab safety in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in phase 2 and 3 clinical trials

Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension

Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials

Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST)

Wirksamkeit und Sicherheit von Fumarsäureestern in Kombination mit Phototherapie bei Patienten mit moderater bis schwerer Plaque‐Psoriasis (FAST)

Social protection systems, redistribution and growth in Latin America

Suchergebnisse filtern